Buspirone in ADHD

J Gordon Millichap

doi:10.15844/pedneurbriefs-12-4-12

Pediatric Neurology Briefs (Apr 1998)

Buspirone in ADHD

J Gordon Millichap

Affiliations

J Gordon Millichap: Northwestern University Feinberg School of Medicine

DOI: https://doi.org/10.15844/pedneurbriefs-12-4-12
Journal volume & issue: Vol. 12, no. 4
pp. 32 – 32

Abstract

Read online

Buspirone monotherapy (0.5 mg/kg daily for 6 weeks) was evaluated in 12 children (10 boys, 2 girls), aged 6 to 12 years, with ADHD at the Maudsley Hospital, London, UK.

Published in Pediatric Neurology Briefs

ISSN: 1043-3155 (Print); 2166-6482 (Online)
Publisher: Pediatric Neurology Briefs Publishers
Country of publisher: United States
LCC subjects: Medicine: Pediatrics; Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://pediatricneurologybriefs.com

About the journal

Abstract

Keywords